Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management RecommendationsHope Northrup, Mary E. Aronow, E. Martina Bebin et al.|Pediatric Neurology|2021Cited by 727
COHORT 1-4 RESULTS FROM A PHASE 1/2 CLINICAL TRIAL OF AN AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA (GSDIA)David Rodriguez‐Buritica, Eric Crombez, Rebecca Riba‐Wolman et al.|Molecular Genetics and Metabolism|2022Cited by 1
A Phase 1/2 first-in-human study to evaluate the safety, tolerability, and pharmacokinetics of UX053 in patients with glycogen storage disease type IIIDavid Rodriguez‐Buritica, Andrew Grimm, Tahseen Mozaffar et al.|Molecular Genetics and Metabolism|2024Cited by 0